Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Clinical trial NCT02629796 · COMPLETED
Trial details
- NCT number
- NCT02629796
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-04-16
- Primary completion
- 2021-11-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.